Endurant Iis
Payments companies reported to CMS as associated with Endurant Iis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Endurant Iis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Endurant Iis
These are the largest totals companies reported as associated with Endurant Iis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ross Milner | Chicago, IL | Vascular Surgery | $227,003.95 |
| Frank Arko | Charlotte, NC | Vascular Surgery | $209,792.10 |
| Brant Ullery | Wilsonville, OR | Vascular Surgery | $134,405.08 |
| Jean Panneton | Virginia Beach, VA | Vascular Surgery | $104,919.21 |
| Jordan Knepper | East Lansing, MI | Vascular Surgery | $74,909.41 |
| Trissa Babrowski | Chicago, IL | Vascular Surgery | $73,207.02 |
| Danielle Pineda | Pomona, NJ | Vascular Surgery | $70,083.15 |
| Apostolos Tassiopoulos | Stony Brook, NY | Vascular Surgery | $54,589.59 |
| Jeffrey Jim | Saint Louis, MO | Vascular Surgery | $49,459.36 |
| Elizabeth Blazick | Portland, ME | Surgery | $45,405.48 |
Prescribed Endurant Iis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.